23andMe to be acquired by co-founder’s nonprofit

TechCrunch reports that 23andMe has been acquired by co-founder and former CEO Anne Wojcicki’s nonprofit TTAM Research Institute for $305 million after leading U.S. biotechnology firm Regeneron Pharmaceuticals, which was initially reported to purchase the firm for $256 million, refused to challenge the bid.SCM feed for Endpoint/Device SecurityRead More